Skip to content Skip to navigation

Experience

Stanford Genome Technology Center (SGTC)                                                                            2014-2018

Department of Biochemistry, Stanford University

Postdoctoral Research Fellow, Advisor: Prof. Ronald W. Davis and Prof. Lars M. Steinmetz

  • Showed the first demonstration of magnetic levitation of cells and made breakthroughs in cell sorting.
  • Enabled ultrasensitive density measurements of single cells - creating a label-free and chemistry-free method to isolate circulating tumor cells and emboli from blood with applications in drug screening and precision medicine.
  • Developed an inexpensive, rapid and portable technology for antibiotic susceptibility test (AST), which significantly reduces the testing time from “days” to “an hour”.
  • Established and led collaborations with academic research groups from various disciplines: Stanford University School of Medicine, Case Western Reserve University, California Institute of Technology, NASA Jet Propulsion Laboratory (JPL), University of San Francisco (UCSF), Canadian Blood Bank (Canada), The European Molecular Biology Laboratory, Heidelberg, Germany (EMBL).
  • Supervised 3 PhD students at Bioengineering and EE programs at Stanford University.
  • Supervised 3 visiting PhD students and 2 research associates with backgrounds in bioengineering, biology, chemistry and materials science.

 

Brown University, Nanomedicine Laboratory                                                                                2009-2013

Ph.D. Candidate, Advisor: Prof. Thomas J. Webster                                                          

  • Integrated nanotechnology and metabolic stimulation to create various “unusual” nanomaterial and nano-therapeutics designs.
  • Developed new magnetic nanoparticles with different chemistries and showed that these nanoparticles outperform and eradicate biofilms “100 times better” than the conventional antibiotics used in the clinic (i.e., vancomycin, “the antibiotic of last resort”).
  • Took an unconventional approach and showed, for the first time, the importance of extracellular metabolic microenvironment for nano-inspired biosystems.
  • Created inexpensive methods to fabricate nanostructured medical devices and showed that bacterial growth decreases on nanorough surfaces.
  • Supervised a master’s student and an undergraduate team (4 students) with backgrounds in biomedical engineering, biology and neuroscience.

 

Harvard-MIT Division of Health Sciences and Technology (HST)                                             June- September 2006                  

Harvard Medical School 

Visiting Student

  • Created a novel, simple and inexpensive method to construct 3D cell-laden macroporous agarose scaffolds.
  • Developed model systems to optimize printed 3D constructs formed by cell-laden hydrogels.
  • Analyzed the spatial distribution of cells within 3D agarose scaffolds in single and dual perfusion microfluidic channel constructs.